These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 8898532)

  • 1. Neuroleptic dosing in Asian and Hispanic outpatients with schizophrenia.
    Ruiz S; Chu P; Sramek J; Rotavu E; Herrera J
    Mt Sinai J Med; 1996; 63(5-6):306-9. PubMed ID: 8898532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic dosing in Hispanic and Asian Inpatients with schizophrenia.
    Collazo Y; Tam R; Sramek J; Herrera J
    Mt Sinai J Med; 1996; 63(5-6):310-3. PubMed ID: 8898533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnic comparisons of antipsychotic use in schizophrenia.
    Wheeler A; Humberstone V; Robinson E
    Aust N Z J Psychiatry; 2008 Oct; 42(10):863-73. PubMed ID: 18777230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic prescription for Chinese schizophrenics in Hong Kong.
    Chiu H; Lee S; Leung CM; Wing YK
    Aust N Z J Psychiatry; 1992 Jun; 26(2):262-4. PubMed ID: 1353673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial differences in the use of adjunctive psychotropic medications for patients with schizophrenia.
    Mallinger JB; Lamberti SJ
    J Ment Health Policy Econ; 2007 Mar; 10(1):15-22. PubMed ID: 17417044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.
    Mishara AL; Goldberg TE
    Biol Psychiatry; 2004 May; 55(10):1013-22. PubMed ID: 15121486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The impact of antipsychotic medication on the incidence and the costs of inpatient treatment in people with schizophrenia: results from a prospective observational study].
    Kilian R; Angermeyer MC
    Psychiatr Prax; 2004 Apr; 31(3):138-46. PubMed ID: 15042477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the clinical and social determinants of prescribing anticholinergic medication for Chinese patients with schizophrenia.
    Xiang YT; Weng YZ; Leung CM; Tang WK; Sandor UG
    Hum Psychopharmacol; 2007 Apr; 22(3):173-80. PubMed ID: 17397098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2D6 genotype predicts antipsychotic side effects in schizophrenia inpatients: a retrospective matched case-control study.
    Kobylecki CJ; Jakobsen KD; Hansen T; Jakobsen IV; Rasmussen HB; Werge T
    Neuropsychobiology; 2009; 59(4):222-6. PubMed ID: 19521114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of antipsychotic treatment for schizophrenia in Hong Kong.
    Yip KC; Ungvari GS; Cheung HK; Ng FS; Lau ST
    Chin Med J (Engl); 1997 Oct; 110(10):792-6. PubMed ID: 9642312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
    Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
    Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of neuroleptic drugs in Italian mental health services: a survey in Piedmont.
    Tibaldi G; Munizza C; Bollini P; Pirfo E; Punzo F; Gramaglia F
    Psychiatr Serv; 1997 Feb; 48(2):213-7. PubMed ID: 9021853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic blood levels in outpatient maintenance therapy of schizophrenia.
    Sajadi C; Smith RC; Shvartsburd A; Morton V; Mirabi M; Gordon J
    Psychopharmacol Bull; 1984; 20(1):110-3. PubMed ID: 6144129
    [No Abstract]   [Full Text] [Related]  

  • 20. Ethnic differences in the neuroleptic treatment of schizophrenia.
    Ruiz P; Varner RV; Small DR; Johnson BA
    Psychiatr Q; 1999; 70(2):163-72. PubMed ID: 10392410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.